Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAEPS (Basic)EPS (Weighted Average and Diluted)Non Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Summit Therapeutics (SMMT) Tax Rate (2016 - 2020)

Historic Tax Rate for Summit Therapeutics (SMMT) over the last 5 years, with Q1 2020 value amounting to 17.94%.

  • Summit Therapeutics' Tax Rate fell 314100.0% to 17.94% in Q1 2020 from the same period last year, while for Mar 2020 it was 27.59%, marking a year-over-year decrease of 404700.0%. This contributed to the annual value of 0.4% for FY2020, which is 5300.0% up from last year.
  • Per Summit Therapeutics' latest filing, its Tax Rate stood at 17.94% for Q1 2020, which was down 314100.0% from 9.37% recorded in Q4 2019.
  • Over the past 5 years, Summit Therapeutics' Tax Rate peaked at 13.47% during Q1 2019, and registered a low of 45.42% during Q4 2017.
  • Over the past 5 years, Summit Therapeutics' median Tax Rate value was 14.22% (recorded in 2018), while the average stood at 11.32%.
  • Its Tax Rate has fluctuated over the past 5 years, first surged by 318600bps in 2018, then crashed by -314100bps in 2020.
  • Quarter analysis of 5 years shows Summit Therapeutics' Tax Rate stood at 16.6% in 2016, then skyrocketed by 100bps to 0.01% in 2017, then tumbled by -114433bps to 13.56% in 2018, then skyrocketed by 31bps to 9.37% in 2019, then plummeted by -91bps to 17.94% in 2020.
  • Its Tax Rate stands at 17.94% for Q1 2020, versus 9.37% for Q4 2019 and 17.07% for Q3 2019.